Dispelling common myths about the flu vaccine
November 29, 2012 in Medications
Every fall, people wonder whether to get an influenza or flu shot.
Some people get them faithfully while others refuse, many because of the various myths that surround the vaccine.
Since the benefits outweigh the potential side effects, Dr. Cindy Whitener, infectious disease specialist at Penn State Milton S. Hershey Medical Center, recommends everyone get the flu shot. Whitener dispels a few myths that prevent skeptics from being vaccinated:
The flu shot will give me the flu.
False: "Some people will get a local reaction where they get the shot, and some might feel achy or feverish for a day or two," Whitener said. "That isn't actual flu, but a reaction to the components in the vaccine."
I don't need the flu shot every year.
False: "Since our antibody response wanes a bit each year we need that boost," Whitener said. In addition, the viral strains that circulate vary from year to year so flu shots differ yearly. Researchers predict which three strains are most likely to circulate and the shot is adjusted accordingly.
It's too late to get the shot.
False: "Since you cannot predict when flu is going to hit a certain region, there's no deadline," Whitener said. While flu is commonly expected in January or February, influenza is possible nine months out of the year (September through May), so the vaccine is often offered through spring. Once flu has hit the area, it's still not too late, although it takes about two weeks for the shot to be effective.
I've already had the flu so I don't need the shot.
False: "Unfortunately, it is possible to get the flu more than once because of the multiple strains that circulate," Whitener said. "If you've already had it, it's worth getting a flu shot to protect yourself from those other strains. In addition, people think they've had the flu but really it was a different, flu-like virus."
It's just the flu. I don't need my doctor.
False: People should call their doctor if they believe they have the flu early on, especially if they have underlying medical conditions or if the patient is older than 65 or younger than 2. Antiviral medicines, if given early, can lessen symptoms and shorten the duration of the illness. "People need to see their doctor if they're having fevers beyond a day or two and they believe they're getting worse rather than better," Whitener said. High fever and trouble breathing are of particular concern.
Expectant mothers should not get the flu.
False: The opposite is true. Doctors recommend flu shots for pregnant women because of a high risk of severe illness. There's no evidence supporting increased risk to the baby if a flu shot is given to the mother.
While Whitener recommends that everyone get a flu shot, the people who need the vaccine most are anyone older than 65, young children, pregnant women, anyone with underlying medical conditions, and anyone who comes in contact with people at risk including family members and health care workers. It is not recommended for anyone with a severe egg allergy (there are traces of egg in the vaccine) and anyone who has experienced a severe reaction to the flu shot in the past. Both situations are serious and should be discussed with a doctor.
Provided by
Pennsylvania State University
-
1 in 3 Americans already got a flu shot this year
Dec 03, 2010 |
not rated yet |
0
-
This year's flu vaccine guards against new strains
Sep 27, 2012 |
not rated yet |
0
-
No Excuses: Flu vaccination myths addressed
Oct 12, 2012 |
not rated yet |
0
-
Flu season: How many shots?
Aug 30, 2009 |
not rated yet |
0
-
Pediatrician shares why children need flu shots
Oct 20, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
Medications
5 hours ago |
not rated yet |
0
Merck ends development of Parkinson's disease drug
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications
May 23, 2013 |
1 / 5 (1) |
0
J&J expects 10-plus new drug applications by 2017
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications
May 23, 2013 |
5 / 5 (1) |
0
Experts favor US approval of Merck sleeping pill (Update)
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications
May 22, 2013 |
not rated yet |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
May 22, 2013 |
not rated yet |
0
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Driving and hands-free talking lead to spike in errors, study shows
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
Comorbidities common with alopecia areata
(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.